Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challenges.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples